By Louis Navellier of
Comstock Homebuilding (CHCI)Sector: Household Durables Market Cap: $28.6 million Comstock Homebuilding ( CHCI) is a multi-faceted real estate development company engaged in the development of for-sale residential and mixed use products operating out of the Washington, D.C. metro area. Since this time in 2009, CHCI has gained 742.5% on its shares and its largest increase came in April, when it jumped 117% in one week. Coming off consecutive profitable quarters, Comstock could be a good addition to a portfolio at its current $1.78.
Axcelis Technologies (ACLS)Sector: Semiconductors and Semiconductor Equipment Market Cap: $180.1 million The Massachusetts-based Axcelis Technologies ( ACLS) engages in the design, manufacture and servicing of capital equipment for the semiconductor manufacturing industry worldwide. Axcelis provides its services for clients such as IBM, Texas Instruments, and Samsung. Since January ACLS has gone up by 29% and has been showing steady and consistent growth which outpaces its industry rivals, not to mention being half the price with twice the return at $1.83 per share.
Joe's Jeans (JOEZ)Sector: textiles Apparel and Luxury Goods Market Cap: $128.3 million Joe's Jeans ( JOEZ) sources and distributes its branded apparel products to over 1,200 retail doors in the U.S. and abroad with its competitive advantages and industry expertise in denim-wear and denim-related products. The company recently announced a 51% increase in net sales for the quarter ending July 15. With stock already showing an increase in return of 237.7% from the same time last summer, JOEZ might turn out to be a steal at its current asking price of $2.06.
Renhuang Pharmaceuticals (CBP)Sector: Personal Products Market Cap: $74.5 million Renhuang Pharmaceuticals ( CBP) is a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines. Renhuang's key product line is the Siberian Ginseng (Acanthopanax) based product series, a natural medicine effective in treating depression, melancholy and other nerve regulating products. Shares of CBP are currently trading for just more than $2 which marks an approximate 100% increase in the past six months.